The gut microbiome in systemic lupus erythematosus: lessons from rheumatic fever

Nat Rev Rheumatol. 2024 Mar;20(3):143-157. doi: 10.1038/s41584-023-01071-8. Epub 2024 Feb 6.

Abstract

For more than a century, certain bacterial infections that can breach the skin and mucosal barriers have been implicated as common triggers of autoimmune syndromes, especially post-infection autoimmune diseases that include rheumatic fever and post-streptococcal glomerulonephritis. However, only in the past few years has the importance of imbalances within our own commensal microbiota communities, and within the gut, in the absence of infection, in promoting autoimmune pathogenesis become fully appreciated. A diversity of species and mechanisms have been implicated, including disruption of the gut barrier. Emerging data suggest that expansions (or blooms) of pathobiont species are involved in autoimmune pathogenesis and stimulate clonal expansion of T cells and B cells that recognize microbial antigens. This Review discusses the relationship between the gut microbiome and the immune system, and the potential consequence of disrupting the community balance in terms of autoimmune development, focusing on systemic lupus erythematosus. Notably, inter-relationships between expansions of certain members within gut microbiota communities and concurrent autoimmune responses bear features reminiscent of classical post-infection autoimmune disease. From such insights, new therapeutic opportunities are being considered to restore the balance within microbiota communities or re-establishing the gut-barrier integrity to reinforce immune homeostasis in the host.

Publication types

  • Review

MeSH terms

  • Autoimmune Diseases*
  • Gastrointestinal Microbiome*
  • Humans
  • Lupus Erythematosus, Systemic*
  • Microbiota*
  • Rheumatic Fever* / complications